AbbVie, IMF Team Up to Study Gene Mutation in Myeloma Outcomes
News
AbbVie and the International Myeloma Foundation are collaborating to study the role of a genetic mutation — the t(11;14) translocation — in multiple myeloma treatments and outcomes. The main goal for AbbVie ... Read more